In this episode of the Eye on A.I. podcast, host Craig Smith interviews Yoshua Bengio, one of the founding fathers of deep learning and a Turing Award winner. Bengio shares his insights on the famous pause letter, which he signed along with other prominent A.I. researchers, calling for a more responsible approach to the development of A.I. technologies. He discusses the potential risks associated with increasingly powerful A.I. models and the importance of ensuring that models are developed in a way that aligns with our ethical values. Bengio also talks about his latest research on world models and inference machines, which aim to provide A.I. systems with the ability to reason for reality and make more informed decisions. He explains how these models are built and how they could be used in a variety of applications, such as autonomous vehicles and robotics. Throughout the podcast, Bengio emphasises the need for interdisciplinary collaboration and the importance of addressing the ethical implications of A.I. technologies. Don't miss this insightful conversation with one of the most influential figures in A.I. on Eye on A.I. podcast! Craig Smith Twitter: https://twitter.com/craigssEye on A.I. Twitter: https://twitter.com/EyeOn_AI
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare